{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:26:47Z","timestamp":1762144007593},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1038\/sj.ijo.0801472","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T16:33:01Z","timestamp":1032453181000},"page":"84-94","source":"Crossref","is-referenced-by-count":49,"title":["Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade"],"prefix":"10.1038","volume":"25","author":[{"given":"O Della","family":"Zuana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sadlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"F\u00e9l\u00e9tou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Tisserand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"de Montrion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JF","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Duhault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JA","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Levens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,1,25]]},"reference":[{"key":"BF0801472_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3181\/00379727-218-44296","volume":"218","author":"LL Bernardis","year":"1998","unstructured":"Bernardis LL, Bellinger LL . The dorsomedial hypothalamic nucleus revisited: 1998 update Proc Soc Exp Biol Med 1998 218: 284\u2013306.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF0801472_CR2","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1210\/endo.131.6.1446635","volume":"131","author":"A Sahu","year":"1992","unstructured":"Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP . Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats Endocrinology 1992 131: 2979\u20132985.","journal-title":"Endocrinology"},{"key":"BF0801472_CR3","first-page":"R2112","volume":"273","author":"A Stricker-Krongrad","year":"1997","unstructured":"Stricker-Krongrad A, Kozak R, Burlet C, Nicolas JP, Beck B . Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats Am J Physiol 1997 273: R2112\u2013R2116.","journal-title":"Am J Physiol"},{"key":"BF0801472_CR4","first-page":"E589","volume":"270","author":"T Yoshihara","year":"1996","unstructured":"Yoshihara T, Honma S, Honma K . Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus Am J Physiol 1996 270: E589\u2013E595.","journal-title":"Am J Physiol"},{"key":"BF0801472_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0167-0115(98)00085-8","volume":"75-76","author":"CL Marin-Bivens","year":"1998","unstructured":"Marin-Bivens CL, Kalra SP, Olster DH . Intraventricular injection of neuropeptide Y antisera curbs weight gain and feeding, and increases the display of sexual behaviors in obese Zucker female rats Regul Pept 1998 75-76: 327\u2013334.","journal-title":"Regul Pept"},{"key":"BF0801472_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0167-0115(95)00110-W","volume":"59","author":"MG Hulsey","year":"1995","unstructured":"Hulsey MG, Pless CM, White BD, Martin RJ . ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release Regul Pept 1995 59: 207\u2013214.","journal-title":"Regul Pept"},{"key":"BF0801472_CR7","first-page":"R1500","volume":"274","author":"A Ishihara","year":"1998","unstructured":"Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T . A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats Am J Physiol 1998 274: R1500\u2013R1504.","journal-title":"Am J Physiol"},{"key":"BF0801472_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0166-2236(96)01057-0","volume":"20","author":"AG Blomqvist","year":"1997","unstructured":"Blomqvist AG, Herzog H . Y-receptor subtypes\u2014how many more? Trends Neurosci 1997 20: 294\u2013298.","journal-title":"Trends Neurosci"},{"key":"BF0801472_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0167-0115(98)00089-5","volume":"75\u201376","author":"P Wyss","year":"1998","unstructured":"Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, Criscione L . The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes Regul Pept 1998 75\u201376: 363\u2013371.","journal-title":"Regul Pept"},{"key":"BF0801472_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0167-0115(98)00097-4","volume":"75\u201376","author":"AO Schaffhauser","year":"1998","unstructured":"Schaffhauser AO, Whitebread S, Haener R, Hofbauer KG, Stricker-Krongrad A . Neuropeptide Y Y1 receptor antisense oligodeoxynucleotides enhance food intake in energy-deprived rats Regul Pept 1998 75\u201376: 417\u2013423.","journal-title":"Regul Pept"},{"key":"BF0801472_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.bjp.0702084","volume":"125","author":"HA Wieland","year":"1998","unstructured":"Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN . Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents Br J Pharmacol 1998 125: 549\u2013555.","journal-title":"Br J Pharmacol"},{"key":"BF0801472_CR12","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1097\/00001756-199611040-00075","volume":"7","author":"FJ Lopez-Valpuesta","year":"1996","unstructured":"Lopez-Valpuesta FJ, Nyce JW, Myers RD . NPY-Y1 receptor antisense injected centrally in rats causes hyperthermia and feeding Neuroreport 1996 7: 2781\u20132784.","journal-title":"Neuroreport"},{"key":"BF0801472_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1677\/joe.0.1590307","volume":"159","author":"M Tang-Christensen","year":"1998","unstructured":"Tang-Christensen M, Kristensen P, Stidsen CE, Brand CL, Larsen PJ . Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y J Endocrinol 1998 159: 307\u2013312.","journal-title":"J Endocrinol"},{"key":"BF0801472_CR14","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2337\/diab.46.11.1792","volume":"46","author":"AO Schaffhauser","year":"1997","unstructured":"Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG . Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides Diabetes 1997 46: 1792\u20131798.","journal-title":"Diabetes"},{"key":"BF0801472_CR15","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI4188","volume":"102","author":"L Criscione","year":"1998","unstructured":"Criscione L, Rigollier P, Batzl-Hartmann C, Rueger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, Heurich RO, Walker MW, Chiesi M, Schilling W, Hofbauer KG, Levens N . Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor J Clin Invest 1998 102: 2136\u20132145.","journal-title":"J Clin Invest"},{"key":"BF0801472_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/joe.0.1570169","volume":"157","author":"S Dryden","year":"1998","unstructured":"Dryden S, Pickavance L, Tidd D, Williams G . The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus J Endocrinol 1998 157: 169\u2013175.","journal-title":"J Endocrinol"},{"key":"BF0801472_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0165-6147(99)01319-X","volume":"20","author":"A Bischoff","year":"1999","unstructured":"Bischoff A, Michel MC . Emerging functions for neuropeptide Y5 receptors Trends Pharmacol Sci 1999 20: 104\u2013106.","journal-title":"Trends Pharmacol Sci"},{"key":"BF0801472_CR18","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0021-9258(17)41954-5","volume":"269","author":"A Townsend-Nicholson","year":"1994","unstructured":"Townsend-Nicholson A, Schofield PR . A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding J Biol Chem 1994 269: 2373\u20132376.","journal-title":"J Biol Chem"},{"key":"BF0801472_CR19","first-page":"888","volume":"251","author":"MF Jarvis","year":"1989","unstructured":"Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M . [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain J Pharmacol Exp Ther 1989 251: 888\u2013893.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0801472_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0014-2999(79)90202-4","volume":"55","author":"P Greengrass","year":"1979","unstructured":"Greengrass P, Bremner R . Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors Eur J Pharmacol 1979 55: 323\u2013326.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1600-0773.1991.tb01308.x","volume":"69","author":"S Uhlen","year":"1991","unstructured":"Uhlen S, Wikberg JE . Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding Pharmacol Toxicol 1991 69: 341\u2013350.","journal-title":"Pharmacol Toxicol"},{"key":"BF0801472_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/BF00971514","volume":"12","author":"DE Murphy","year":"1987","unstructured":"Murphy DE, Snowhill EW, Williams M . Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay Neurochem Res 1987 12: 775\u2013781.","journal-title":"Neurochem Res"},{"key":"BF0801472_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0024-3205(84)90340-0","volume":"35","author":"HR Lee","year":"1984","unstructured":"Lee HR, Roeske WR, Yamamura HI . High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart Life Sci 1984 35: 721\u2013732.","journal-title":"Life Sci"},{"key":"BF0801472_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-2999(91)90118-A","volume":"194","author":"M Trampus","year":"1991","unstructured":"Trampus M, Ongini E, Varani K, Borea PA . The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain Eur J Pharmacol 1991 194: 17\u201323.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0014-2999(89)90516-5","volume":"173","author":"M Terai","year":"1989","unstructured":"Terai M, Hidaka K, Nakamura Y . Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum Eur J Pharmacol 1989 173: 177\u2013182.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1128\/AAC.32.2.190","volume":"32","author":"A Tsuji","year":"1988","unstructured":"Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H . Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes Antimicrob Agents Chemother 1988 32: 190\u2013194.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF0801472_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF01993161","volume":"33","author":"S Dini","year":"1991","unstructured":"Dini S, Caselli GF, Ferrari MP, Giani R, Clavenna G . Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lung Agents Actions 1991 33: 181\u2013184.","journal-title":"Agents Actions"},{"key":"BF0801472_CR28","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1073\/pnas.87.5.1658","volume":"87","author":"M Ruat","year":"1990","unstructured":"Ruat M, Traiffort E, Bouthenet ML, Schwartz JC, Hirschfeld J, Buschauer A, Schunack W . Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes Proc Natl Acad Sci USA 1990 87: 1658\u20131662.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF0801472_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1472-8206.1991.tb00704.x","volume":"5","author":"I Angel","year":"1991","unstructured":"Angel I, Bidet S . The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K-channel agonists or antagonists other than sulphonylureas Fundam Clin Pharmacol 1991 5: 107\u2013115.","journal-title":"Fundam Clin Pharmacol"},{"key":"BF0801472_CR30","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1016\/S0021-9258(18)55434-X","volume":"265","author":"J Vazquez","year":"1990","unstructured":"Vazquez J, Feigenbaum P, King VF, Kaczorowski GJ, Garcia ML . Characterization of high affinity binding sites for charybdotoxin insynaptic plasma membranes from rat brain. Evidence for a direct association with an inactivating, voltage-dependent, potassium channel J Biol Chem 1990 265: 15564\u201315571.","journal-title":"J Biol Chem"},{"key":"BF0801472_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1476-5381.1990.tb13002.x","volume":"99","author":"MH Richards","year":"1990","unstructured":"Richards MH . Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors Br J Pharmacol 1990 99: 753\u2013761.","journal-title":"Br J Pharmacol"},{"key":"BF0801472_CR32","first-page":"9","volume":"39","author":"LA Pabreza","year":"1991","unstructured":"Pabreza LA, Dhawan S, Kellar K . [3H]cytisine binding to nicotinic cholinergic receptors in brain Mol Pharmacol 1991 39: 9\u201312.","journal-title":"Mol Pharmacol"},{"key":"BF0801472_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-2999(91)90063-V","volume":"192","author":"MA Sills","year":"1991","unstructured":"Sills MA, Fagg G, Pozza M, Angst C, Brundish DE, Hurt SD, Wilusz EJ, Williams M . [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain Eur J Pharmacol 1991 192: 19\u201324.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0014-2999(79)90142-0","volume":"55","author":"SR Childers","year":"1979","unstructured":"Childers SR, Creese I, Snowman AM, Synder SH . Opiate receptor binding affected differentially by opiates and opioid peptides Eur J Pharmacol 1979 55: 11\u201318.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR35","first-page":"687","volume":"16","author":"SJ Peroutka","year":"1979","unstructured":"Peroutka SJ, Snyder SH . Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol Mol Pharmacol 1979 16: 687\u2013699.","journal-title":"Mol Pharmacol"},{"key":"BF0801472_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1476-5381.1995.tb14977.x","volume":"115","author":"DW Bonhaus","year":"1995","unstructured":"Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM . The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors Br J Pharmacol 1995 115: 622\u2013628.","journal-title":"Br J Pharmacol"},{"key":"BF0801472_CR37","first-page":"303","volume":"33","author":"D Hoyer","year":"1988","unstructured":"Hoyer D, Neijt HC . Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding Mol Pharmacol 1988 33: 303\u2013309.","journal-title":"Mol Pharmacol"},{"key":"BF0801472_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0014-2999(93)90100-V","volume":"237","author":"Y Shirayama","year":"1993","unstructured":"Shirayama Y, Nishikawa T, Umino A, Takahashi K . p-Chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain Eur J Pharmacol 1993 237: 117\u2013126.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR39","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/j.1471-4159.1988.tb02479.x","volume":"50","author":"JO Marcusson","year":"1988","unstructured":"Marcusson JO, Bergstrom M, Eriksson K, Ross SB . Characterization of [3H]paroxetine binding in rat brain J Neurochem 1988 50: 1783\u20131790.","journal-title":"J Neurochem"},{"key":"BF0801472_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0014-2999(88)90122-7","volume":"148","author":"J Vignon","year":"1988","unstructured":"Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R . [3H]N-[1-(2 benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]-BTCP): a new phencyclidine analog selective for the dopamine uptake complex Eur J Pharmacol 1988 148: 427\u2013436.","journal-title":"Eur J Pharmacol"},{"key":"BF0801472_CR41","first-page":"427","volume":"260","author":"SM Tejani-Butt","year":"1992","unstructured":"Tejani-Butt SM . [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding J Pharmacol Exp Ther 1992 260: 427\u2013436.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0801472_CR42","first-page":"1145","volume":"45","author":"S Perovic","year":"1995","unstructured":"Perovic S, Muller WE . Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors Arzneimittelforschung 1995 45: 1145\u20131148.","journal-title":"Arzneimittelforschung"},{"key":"BF0801472_CR43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.bjp.0702594","volume":"127","author":"M F\u00e9l\u00e9tou","year":"1999","unstructured":"F\u00e9l\u00e9tou M, Beauverger P, Galizzi, J-P., Nicolas, J-P., Rodriguez M, Boutin, JA., Duhault J . NPY receptor subtype in the rabbit ileum Br J Pharmacol 1999 127: 795\u2013801.","journal-title":"Br J Pharmacol"},{"key":"BF0801472_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0167-0115(98)00072-X","volume":"75\u201376","author":"M F\u00e9l\u00e9tou","year":"1998","unstructured":"F\u00e9l\u00e9tou M, Rodriguez M, Beauverger P, Germain M, Imbert J, Dromaint S, Macia C, Bourrienne A, Henlin J-M, Nicolas J-P, Boutin, JA, Galizzi J-P, Fauch\u00e8re J-L, Canet E, Duhault J . NPY receptor subtypes involved in the contraction of the proximal colon of the rat Regul Pept 1998 75\u201376: 221\u2013229.","journal-title":"Regul Pept"},{"key":"BF0801472_CR45","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1210\/endo.140.9.6985","volume":"140","author":"PD Raposinho","year":"1999","unstructured":"Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML . Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype Endocrinology 1999 140: 4046\u20134055.","journal-title":"Endocrinology"},{"key":"BF0801472_CR46","first-page":"1031","volume":"289","author":"S Iyengar","year":"1999","unstructured":"Iyengar S, Li DL, Simmons RM . Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding? J Pharmacol Exp Ther 1999 289: 1031\u20131040.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0801472_CR47","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/13514","volume":"5","author":"P Naveilhan","year":"1999","unstructured":"Naveilhan P, Hassani H, Canals JM, Ekstrand AJ, Larefalk A, Chhajlani V, Arenas E, Gedda K, Svensson L, Thoren P, Ernfors P . Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor Nature Med 1999 5: 1188\u20131193.","journal-title":"Nature Med"},{"key":"BF0801472_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0304-3940(88)90419-3","volume":"85","author":"J Guy","year":"1988","unstructured":"Guy J, Pelletier G, Bosler O . Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus Neurosci Lett 1988 85: 9\u201313.","journal-title":"Neurosci Lett"},{"key":"BF0801472_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0006-8993(96)00329-0","volume":"724","author":"S Dryden","year":"1996","unstructured":"Dryden S, Frankish HM, Wang Q, Williams G . Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine Brain Res 1996 724: 232\u2013237.","journal-title":"Brain Res"},{"key":"BF0801472_CR50","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1097\/00001756-199712010-00020","volume":"8","author":"PJ Currie","year":"1997","unstructured":"Currie PJ, Coscina DV . Stimulation of 5-HT(2A\/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding Neuroreport 1997 8: 3759\u20133762.","journal-title":"Neuroreport"},{"key":"BF0801472_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0306-4522(95)00566-8","volume":"72","author":"S Dryden","year":"1996","unstructured":"Dryden S, Frankish HM, Wang Q, Pickavance L, Williams G . The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats Neuroscience 1996 72: 557\u2013566.","journal-title":"Neuroscience"},{"key":"BF0801472_CR52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0024-3205(93)90243-V","volume":"53","author":"PJ Wellman","year":"1993","unstructured":"Wellman PJ, Davies BT, Morien A, McMahon L . Modulation of feeding by hypothalamic paraventricular nucleus alpha 1-and alpha 2-adrenergic receptors Life Sci 1993 53: 669\u2013679.","journal-title":"Life Sci"},{"key":"BF0801472_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/0091-3057(84)90309-5","volume":"20","author":"MF Callahan","year":"1984","unstructured":"Callahan MF, Beales M, Oltmans GA . Yohimbine and rauwolscine reduce food intake of genetically obese (obob) and lean mice Pharmacol Biochem Behav 1984 20: 591\u2013599.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF0801472_CR54","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","volume":"11","author":"RM Parker","year":"1999","unstructured":"Parker RM, Herzog H . Regional distribution of Y-receptor subtype mRNAs in rat brain Eur J Neurosci 1999 11: 1431\u20131448.","journal-title":"Eur J Neurosci"},{"key":"BF0801472_CR55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0006-8993(98)00652-0","volume":"805","author":"MM Hagan","year":"1998","unstructured":"Hagan MM, Castaneda E, Sumaya IC, Fleming SM, Galloway J, Moss DE . The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo: implications for limbic function in binge-eating behavior Brain Res 1998 805: 20\u201328.","journal-title":"Brain Res"},{"key":"BF0801472_CR56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0163-7258(95)98598-K","volume":"65","author":"JG Wettstein","year":"1995","unstructured":"Wettstein JG, Earley B, Junien JL . Central nervous system pharmacology of neuropeptide Y Pharmacol Ther 1995 65: 397\u2013414.","journal-title":"Pharmacol Ther"},{"key":"BF0801472_CR57","first-page":"R1711","volume":"266","author":"CR Plata-Salaman","year":"1994","unstructured":"Plata-Salaman CR, Borkoski JP . Chemokines\/intercrines and central regulation of feeding Am J Physiol 1994 266: R1711\u20131715.","journal-title":"Am J Physiol"},{"key":"BF0801472_CR58","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0031-9384(94)90339-5","volume":"56","author":"S Kent","year":"1994","unstructured":"Kent S, Rodriguez F, Kelley KW, Dantzer R . Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat Physiol Behav 1994 56: 1031\u20131036.","journal-title":"Physiol Behav"},{"key":"BF0801472_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0167-0115(99)00108-1","volume":"87","author":"K McCrea","year":"2000","unstructured":"McCrea K, Wisialowski T, Cabrele C, Church B, Beck-Sickinger A, Kraegen E . Herzog 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake Regul Pept 2000 87: 47\u201358.","journal-title":"Regul Pept"},{"key":"BF0801472_CR60","first-page":"R1428","volume":"277","author":"JJ Hwa","year":"1999","unstructured":"Hwa JJ, Witten MB, Williams P, Ghibaudi L, Gao J, Salisbury BG, Mullins D, Hamud F, Strader CD, Parker EM . Activation of the NPY Y5 receptor regulates both feeding and energy expenditure Am J Physiol 1999 277: R1428\u2013R1434.","journal-title":"Am J Physiol"},{"key":"BF0801472_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/bbrc.2000.2696","volume":"272","author":"A Kanatani","year":"2000","unstructured":"Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, Ishii Y, Okabe T, Fukami T . Ihara M 1: L-152, 804: orally active and selective neuropeptide Y Y5 receptor antagonist Biochem Biophys Res Commun 2000 272: 169\u2013173.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF0801472_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0006-8993(00)02285-X","volume":"868","author":"AW Bannon","year":"2000","unstructured":"Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, McCaleb ML . Behavioral characterization of neuropeptide Y knockout mice Brain Res 2000 868: 79\u201387.","journal-title":"Brain Res"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0801472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801472","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:15:38Z","timestamp":1684221338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0801472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["BF0801472"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0801472","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}